Replies to post #522654 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

UK is a minor market for pharmaceuticals. NWBO maybe able to gain approval but as a single payer market, price negotiations are problematic. NWBO will need U.S. FDA approval to be successful as all oncology treatments have required.